amyotrophic lateral sclerosis program(Neuron23 Inc)

N/A

Report date: 2025/01/26 16:16:19
NME

Base Information

Drug Nameamyotrophic lateral sclerosis program(Neuron23 Inc)
Drug Alias NameProgram-3
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNeuroprotectants
TargetsUpdating
Therapy Area/IndicationsAmyotrophic Lateral Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNeuron23 Inc
China Registration ClassN/A

Develop Information

Active CompaniesNeuron23 Inc
Inactive CompaniesN/A
Active IndicationsAmyotrophic Lateral Sclerosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A